lovastatin has been researched along with Hypertension in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.94) | 18.7374 |
| 1990's | 16 (47.06) | 18.2507 |
| 2000's | 12 (35.29) | 29.6817 |
| 2010's | 5 (14.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lenti, S; Mazza, A; Montanaro, F; Rigatelli, G; Schiavon, L; Torin, G | 1 |
| Di Giacomo, E; Lenti, S; Manunta, R; Mazza, A; Rubello, D; Schiavon, L; Tomasi, M; Torin, G; Townsend, DM | 1 |
| Christopher-Stine, L; Isackson, PJ; Kitzmiller, JP; Luzum, JA; Ma, C; Nguyen, LM; Ochs-Balcom, HM; Peltier, W; Tarnopolsky, M; Vladutiu, GD; Weisman, M; Wortmann, RL | 1 |
| Cai, YX; Liang, C; Linck, V; Ma, HP; Ma, J; Niu, N; Song, BL; Sutliff, RL; Thai, TL; Wang, QS; Wu, MM; Yang, X; Yu, XD; Yue, Q; Zhai, YJ; Zhang, BL; Zhang, S; Zhang, ZR; Zou, L | 1 |
| Medvedev, IN; Skoriatina, IA | 1 |
| Duriez, P; Fruchart, JC; Hazzan, M; Kandoussi, A; Martin, F; Noël, C; Staels, B | 1 |
| Dong, J; Fujii, S; Furumoto, T; Goto, D; Imagawa, S; Kaneko, T; Kitabatake, A; Mishima, T; Nakai, Y; Zaman, TA | 1 |
| Aguilar, P; Muñoz Díaz, AB | 1 |
| Dement'ev, VI; Gromnatskiĭ, NI; Medvedev, IN; Osipova, VM; Storozhenko, MV; Volobuev, IV | 1 |
| Cartwright, MS; Donofrio, PD; Jeffery, DR; Nuss, GR | 1 |
| Klose, G | 1 |
| Corynen, S; Dieterle, W; Mann, J; Vaidyanathan, S | 1 |
| Gromnatskiĭ, NI; Medvedev, IN; Osipova, VM; Storozhenko, MV; Volobuev, IV | 1 |
| Edelstein, CL; Falk, S; McFann, K; Schrier, RW; Tao, Y; Zafar, I | 1 |
| Chin, JP; Dart, AM | 1 |
| D'Agostino, LC; D'Agostino, RB; Kannel, WB; Stepanians, MN | 1 |
| Bratland, B; Dahlöf, B; Gisholt, K; Os, I; Syvertsen, JO; Tretli, S | 1 |
| Neugarten, J; Rubin, R; Sablay, L; Silbiger, S | 1 |
| Boccuzzi, SJ; Cook, T; Gladstone, P; Higginson, L; Hudgin, R; Krip, G; Lespérance, J; Waters, D | 1 |
| Chan, P; Huang, TY; Lee, C; Lee, YS; Tomlinson, B | 1 |
| Kaysen, GA; Neverov, NI; Tareyeva, IE | 1 |
| Jiang, J; Roman, RJ | 1 |
| Alonso-Galicia, M; Jiang, J; Roman, RJ; Sun, CW | 1 |
| Coelho, OR; Mansur, AP; Nicolau, JC; Ramires, JA; Spósito, AC | 1 |
| Gross, V; Luft, FC; Mervaala, E; Schneider, W; Schunck, WH | 1 |
| Gotto, AM | 1 |
| Atkinson, J; Capdeville-Atkinson, C; Chillon, JM; Limiñana, P; Régrigny, O | 1 |
| Celesia, GG; Kellman, W; Ruosseau, P; Siegel, G; Wolozin, B | 1 |
| Erdmann, B; Gross, V; Honeck, H; Kärgel, E; Luft, FC; Milia, AF; Neunaber, R; Schneider, W; Schunck, WH | 1 |
| D'Agostino, LC; D'Agostino, RB; Kannel, WB; Stepanians, M | 1 |
| Bentivoglio, M; Berioli, S; Conti, R; Corea, L; Osanna, RA; Savino, K; Zollino, L | 1 |
| Anderson, A; Hopper, J; Macaskill, G; McDonald, P; Morgan, T | 1 |
| Edelman, S; Witztum, JL | 1 |
14 trial(s) available for lovastatin and Hypertension
| Article | Year |
|---|---|
The short-term supplementation of monacolin K improves the lipid and metabolic patterns of hypertensive and hypercholesterolemic subjects at low cardiovascular risk.
Topics: Adult; Biological Products; Blood Glucose; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Dietary Supplements; Female; Humans; Hypercholesterolemia; Hypertension; Lipids; Lovastatin; Male; Middle Aged; Risk Factors; Time Factors; Triglycerides | 2018 |
Effect of Monacolin K and COQ10 supplementation in hypertensive and hypercholesterolemic subjects with metabolic syndrome.
Topics: Aged; Anticholesteremic Agents; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Diet, Mediterranean; Dietary Supplements; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Lovastatin; Male; Metabolic Syndrome; Middle Aged; Treatment Outcome; Triglycerides; Ubiquinone | 2018 |
Pharmacokinetic interactions of the oral renin inhibitor aliskiren with lovastatin, atenolol, celecoxib and cimetidine.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Amides; Atenolol; Celecoxib; Cimetidine; Cross-Over Studies; Cyclooxygenase 2 Inhibitors; Drug Interactions; Enzyme Inhibitors; Fumarates; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Lovastatin; Male; Middle Aged; Pyrazoles; Renin; Sulfonamides | 2005 |
HBPRCA Astra Award. Therapeutic restoration of endothelial function in hypercholesterolaemic subjects: effect of fish oils.
Topics: Acetylcholine; Adult; Australia; Awards and Prizes; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Drug Therapy, Combination; Endothelium, Vascular; Female; Fish Oils; Forearm; Humans; Hypercholesterolemia; Hypertension; Lovastatin; Male; Middle Aged; Regional Blood Flow; Simvastatin | 1994 |
Efficacy and tolerability of lovastatin in hypercholesterolemia in patients with systemic hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Diuretics; Drug Tolerance; Female; Humans; Hypercholesterolemia; Hypertension; Lovastatin; Male; Middle Aged; Retrospective Studies; Time Factors; Triglycerides | 1993 |
Effect and tolerability of combining lovastatin with nifedipine or lisinopril.
Topics: Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hypertension; Lisinopril; Lovastatin; Male; Middle Aged; Nifedipine; Quality of Life; Risk Factors | 1993 |
Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy. CCAIT Study Group.
Topics: Adult; Angina, Unstable; Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Lovastatin; Male; Middle Aged; Myocardial Infarction; Placebos; Smoking; Triglycerides | 1996 |
Short-term safety and efficacy of low-dose simvastatin in elderly patients with hypertensive hypercholesterolemia and fasting hyperinsulinemia.
Topics: Aged; Anticholesteremic Agents; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperinsulinism; Hypertension; Lovastatin; Male; Patient Compliance; Simvastatin | 1997 |
Effect of lipid-lowering therapy on the progression of renal disease in nondiabetic nephrotic patients.
Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Cholesterol; Chronic Disease; Creatinine; Diet, Fat-Restricted; Disease Progression; Female; Glomerulonephritis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Lipoproteins; Lovastatin; Male; Middle Aged; Proteinuria | 1997 |
Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril).
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Blood Pressure; Drug Interactions; Enalapril; Female; Heart Rate; Humans; Hypercholesterolemia; Hypertension; Lisinopril; Lovastatin; Male; Middle Aged; Pravastatin | 1999 |
Lipid management in patients at moderate risk for coronary heart disease: insights from the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
Topics: Age Factors; Aged; Anticholesteremic Agents; Coronary Artery Disease; Coronary Disease; Diabetes Mellitus, Type 2; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Lovastatin; Male; Middle Aged; Military Personnel; Practice Guidelines as Topic; Pravastatin; Primary Prevention; Risk; Risk Factors; Sex Factors; Smoking; Texas; Treatment Outcome | 1999 |
Efficacy and tolerability of lovastatin in a six-month study: analysis by gender, age and hypertensive status.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Drug Evaluation; Female; Humans; Hypercholesterolemia; Hypertension; Lovastatin; Male; Middle Aged; Multicenter Studies as Topic; Sex Factors; Triglycerides | 1990 |
[Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide].
Topics: Adult; Aged; Anticholesteremic Agents; Cholesterol; Female; Gemfibrozil; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Lipoproteins, HDL; Lipoproteins, LDL; Lovastatin; Male; Middle Aged; Simvastatin; Triglycerides | 1990 |
Simvastatin in the treatment of hypercholesterolaemia in patients with essential hypertension.
Topics: Adult; Aged; Anticholesteremic Agents; Cholesterol; Dietary Fats, Unsaturated; Female; Humans; Hypercholesterolemia; Hypertension; Lovastatin; Male; Middle Aged; Random Allocation; Simvastatin | 1990 |
20 other study(ies) available for lovastatin and Hypertension
| Article | Year |
|---|---|
Clinical features related to statin-associated muscle symptoms.
Topics: Aged; Atorvastatin; Female; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Logistic Models; Lovastatin; Male; Medical History Taking; Middle Aged; Muscle Weakness; Muscular Diseases; Myalgia; Obesity; Odds Ratio; Pravastatin; Retrospective Studies; Rhabdomyolysis; Risk Factors; Rosuvastatin Calcium; Simvastatin; Smoking; White People | 2019 |
Lovastatin attenuates hypertension induced by renal tubule-specific knockout of ATP-binding cassette transporter A1, by inhibiting epithelial sodium channels.
Topics: Animals; Anticholesteremic Agents; Antihypertensive Agents; ATP Binding Cassette Transporter 1; Epithelial Sodium Channel Blockers; Epithelial Sodium Channels; Hypertension; Kidney Tubules; Lovastatin; Male; Mice, Knockout | 2019 |
[Effect of lovastatin on adhesive and aggregation function of platelets in patients with arterial hypertension and dislipidemia].
Topics: Blood Platelets; Cell Adhesion; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Lipid Peroxidation; Lipids; Lovastatin; Male; Middle Aged; Platelet Aggregation | 2010 |
HMG-CoA reductase inhibition and PPAR- alpha activation both inhibit cyclosporin A induced endothelin-1 secretion in cultured endothelial cells.
Topics: Animals; Aorta; Cattle; Cells, Cultured; Clofibric Acid; Cyclosporine; Endothelin-1; Endothelium, Vascular; Fibric Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Lovastatin; Mevalonic Acid; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2002 |
Increased expression of plasminogen activator inhibitor-1 by mediators of the acute phase response: a potential progenitor of vasculopathy in hypertensives.
Topics: Acute-Phase Reaction; Blotting, Northern; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Interleukin-1; Interleukin-6; Liver Neoplasms; Lovastatin; Mevalonic Acid; Plasminogen Activator Inhibitor 1; RNA, Messenger; Up-Regulation | 2003 |
[Idiopathic membranous nephropathy associated with anti-calcineurin toxicity. Prognosis and other immunosuppressive treatments].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcineurin Inhibitors; Calcium Channel Blockers; Creatinine; Cyclosporine; Drug Therapy, Combination; Glomerulonephritis, Membranous; Humans; Hypercholesterolemia; Hypertension; Hypolipidemic Agents; Immunosuppressive Agents; Kidney Diseases; Lisinopril; Lovastatin; Male; Nephrotic Syndrome; Prednisone; Recurrence; Verapamil | 2004 |
[Thrombocytic hemostasis in hypertensive patients with metabolic syndrome and its correction with lovastatin].
Topics: Anticholesteremic Agents; Data Interpretation, Statistical; Exercise; Female; Humans; Hypertension; Lipid Peroxidation; Lovastatin; Male; Metabolic Syndrome; Middle Aged; Time Factors | 2004 |
Statin-associated exacerbation of myasthenia gravis.
Topics: Atorvastatin; Cytokines; Dysarthria; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Lovastatin; Male; Middle Aged; Mitochondria; Models, Neurological; Muscular Diseases; Myasthenia Gravis; Neural Conduction; Pravastatin; Pyridostigmine Bromide; Pyrroles; Simvastatin; Th2 Cells; Ubiquinone | 2004 |
[The "healthy" patient with hypercholesterolemia].
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Antihypertensive Agents; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Female; Follow-Up Studies; Geriatric Assessment; Health Status; Humans; Hypercholesterolemia; Hypertension; Lipoprotein(a); Lovastatin; Practice Guidelines as Topic; Risk Factors | 2005 |
[Correction of thrombocyte-vascular hemostasis in metabolic syndrome].
Topics: Adult; Anticholesteremic Agents; Blood Platelets; Female; Hemostasis; Humans; Hypertension; Lovastatin; Male; Metabolic Syndrome; Middle Aged | 2006 |
Effect of statin and angiotensin-converting enzyme inhibition on structural and hemodynamic alterations in autosomal dominant polycystic kidney disease model.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Kidney; Lovastatin; Male; Organ Size; Polycystic Kidney, Autosomal Dominant; Renal Circulation | 2007 |
Combined antihypertensive and lipid-lowering therapy in experimental glomerulonephritis.
Topics: Animals; Antihypertensive Agents; Cholesterol; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Hyperlipidemias; Hypertension; Lovastatin; Male; Rats; Rats, Sprague-Dawley | 1994 |
Lovastatin prevents development of hypertension in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Arterioles; Blood Pressure; Extracellular Space; Glomerular Filtration Rate; Hydralazine; Hydrostatic Pressure; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Kidney; Kidney Medulla; Lovastatin; Natriuresis; Rats; Rats, Inbred SHR; Renal Circulation | 1997 |
American Heart Association 70th Scientific Sessions, Orlando.
Topics: Adult; Aged; Anticholesteremic Agents; Antihypertensive Agents; Cardiovascular Diseases; Female; Humans; Hypertension; Lovastatin; Male; Middle Aged; Risk Factors | 1997 |
Lovastatin reduces renal vascular reactivity in spontaneously hypertensive rats.
Topics: Animals; Arterioles; Blood Pressure; GTP-Binding Proteins; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Lovastatin; Norepinephrine; Rats; Rats, Inbred SHR; Renal Circulation; Vasoconstriction; Vasoconstrictor Agents; Vasomotor System; Vasopressins | 1998 |
Chronic effects of lovastatin and bezafibrate on cortical and medullary hemodynamics in deoxycorticosterone acetate-salt hypertensive mice.
Topics: Animals; Anticholesteremic Agents; Bezafibrate; Blood Flow Velocity; Desoxycorticosterone; Diuresis; Hypertension; Hypolipidemic Agents; Kidney Cortex; Kidney Medulla; Lovastatin; Mice; Pressure; Renal Circulation; Vascular Resistance | 1999 |
Effect of lovastatin on cerebral circulation in spontaneously hypertensive rats.
Topics: Animals; Anticholesteremic Agents; Blood Pressure; Cerebrovascular Circulation; Hypertension; Lovastatin; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2000 |
Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cardiovascular Diseases; Cholesterol; Cross-Sectional Studies; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Pravastatin; Prevalence; Retrospective Studies; Risk Factors; Treatment Outcome | 2000 |
Cytochrome P450-dependent renal arachidonic acid metabolism in desoxycorticosterone acetate-salt hypertensive mice.
Topics: Animals; Arachidonic Acid; Bezafibrate; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Desoxycorticosterone; Hydroxyeicosatetraenoic Acids; Hydroxylation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypolipidemic Agents; In Situ Hybridization; Kidney; Lovastatin; Male; Mice; Mice, Inbred Strains; Microsomes; Mixed Function Oxygenases; NADP; Nephrectomy; RNA, Messenger; Sodium Chloride | 2000 |
Hyperkalemia during treatment with HMG-CoA reductase inhibitor.
Topics: Adult; Diabetes Mellitus, Type 1; Humans; Hyperkalemia; Hyperlipoproteinemia Type II; Hypertension; Kidney Diseases; Lovastatin; Male | 1989 |